BDX Chart — Next Bullish Trade

BDX Becton, Dickinson and Company NYQ

$146.24 -1.11 (-0.75%)

Neutral · -0.45σ Grade C

Price chart

Loading 1Y daily…

Financial overlay · last 12 quarters

Quarter	Revenue	Net income	Op income	FCF	Net margin	Op margin
2026-03-31	$4.7B	$-0.3B	$0.6B	$0.5B	-6.6%	13.3%
2025-12-31	$5.3B	$0.4B	$0.7B	$0.5B	7.3%	12.6%
2025-09-30	$5.9B	$0.5B	$0.8B	$1.0B	8.4%	14.0%
2025-06-30	$5.5B	$0.6B	$1.0B	$1.0B	10.4%	17.8%
2025-03-31	$4.5B	$0.3B	$0.5B	$0.0B	6.9%	10.6%
2024-12-31	$nanB	$nanB	$nanB	$nanB	nan%	nan%

Earnings replay · last 20 reports

Date	EPS actual	EPS est	Surprise
2026-05-07	2.90	2.77	+4.5%
2026-02-09	1.34	0.26	+415.4%
2025-11-06	3.96	3.91	+1.1%
2025-08-07	3.68	3.40	+8.2%
2025-05-01	3.35	3.28	+2.1%
2025-02-05	3.43	2.99	+14.7%
2024-11-07	3.81	3.77	+1.1%
2024-08-01	3.50	3.31	+5.8%
2024-05-02	3.17	2.97	+6.8%
2024-02-01	2.68	2.40	+11.6%
2023-11-09	3.42	3.43	-0.1%
2023-08-03	2.96	2.91	+1.6%
2023-05-04	2.86	2.75	+4.0%
2023-02-02	2.98	2.68	+11.0%
2022-11-10	2.75	2.74	+0.4%
2022-08-04	2.66	2.50	+6.5%
2022-05-05	3.18	2.95	+7.9%
2022-02-03	3.64	2.85	+27.5%
2021-11-04	2.59	2.45	+5.5%
2021-08-05	2.74	2.44	+12.2%

Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).

Peer comparison · Healthcare

Ticker ⇅	Mkt cap ⇅	P/E ⇅	Fwd P/E ⇅	P/S ⇅	EV/EBITDA ⇅	P/B ⇅	Gross M ⇅	Rev gr ⇅	EPS gr ⇅	FCF yld ⇅
BDX ★	$40B	25.5	10.9	1.8	9.2	1.7	47.1%	5.2%	—	11.25%
LLY	$1,010B	40.3	25.5	14.0	28.9	32.4	82.8%	55.5%	169.9%	0.91%
UNH	$371B	30.8	19.5	0.8	19.8	3.8	18.8%	2.0%	0.7%	4.77%
JNJ	$580B	27.9	18.9	6.0	17.9	7.1	68.0%	9.9%	-52.9%	2.16%
MRK	$294B	33.5	12.4	4.5	11.4	6.4	76.7%	4.9%	—	4.78%
ABBV	$402B	111.1	14.0	6.4	15.6	-60.5	72.0%	12.4%	-46.2%	5.17%
PFE	$149B	20.0	9.3	2.4	7.9	1.7	74.8%	5.4%	-10.1%	8.29%
TMO	$174B	25.8	17.2	3.9	19.0	3.3	40.9%	6.2%	11.3%	3.17%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Top institutional holders

Top-10 concentration: 46.6%

Holder	Shares	% out
Blackrock Inc.	26,153,411	9.49%
Vanguard Capital Management LLC	18,490,610	6.71%
Vanguard Portfolio Management LLC	15,317,242	5.56%
State Street Corporation	13,822,808	5.02%
First Eagle Investment Management, L	11,928,111	4.33%
Invesco Ltd.	10,174,327	3.69%
T. Rowe Price Investment Management,	9,685,271	3.52%
Massachusetts Financial Services Co.	9,101,454	3.30%
Geode Capital Management, LLC	7,107,263	2.58%
Wellington Management Group, LLP	6,615,230	2.40%

Insider activity · 90d

5 buys / 6 sells · ratio 0.83 · Finnhub

Garrison Michael David SELL 14,272 @ $151.48
Polen Thomas E Jr M 0
Polen Thomas E Jr SELL 110,163 @ $146.35
Polen Thomas E Jr SELL 108,235 @ $146.15
Polen Thomas E Jr M 125,680 @ $126.16
Menziuso Peter BUY 14,258
Feld Michael SELL 21,084 @ $147.35
Huffines Robert Luther BUY 404 @ $149.04
Byington Carrie L BUY 3,699 @ $149.04
Roque Vitor BUY 8,231

Analyst estimates

Finnhub

Low

$150.0

Mean

$180.6923

High

$225.0

Analysts

Recommendation distribution · period 2026-06-01

Revision trend (2026-03-01 → 2026-06-01): net 9 → 9 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

Form	Filed	Description	Action
4	2026-06-11	FORM 4	view ·
4	2026-06-03	FORM 4	view ·
4	2026-06-02	FORM 4	view ·
8-K	2026-05-29	8-K	view ·
4	2026-05-27	FORM 4	view ·
8-K	2026-05-20	8-K	view ·
8-K	2026-05-12	8K	view ·
4	2026-05-08	FORM 4	view ·
4	2026-05-08	FORM 4	view ·
4	2026-05-08	FORM 4	view ·
10-Q	2026-05-07	10-Q	view ·
8-K	2026-05-07	8-K	view ·
8-K	2026-04-29	8-K	view ·
4	2026-04-28	FORM 4	view ·
8-K	2026-04-09	8-K	view ·
4	2026-04-06	FORM 4	view ·
8-K	2026-04-02	8-K	view ·
4	2026-03-27	FORM 4	view ·
4	2026-03-17	FORM 4	view ·
4	2026-03-04	FORM 4	view ·
4	2026-03-04	FORM 4	view ·
4	2026-02-27	FORM 4	view ·
8-K	2026-02-25	8-K	view ·
4	2026-02-18	FORM 4	view ·
4	2026-02-11	4	view ·
8-K	2026-02-10	8-K	view ·
10-Q	2026-02-09	10-Q	view ·
8-K	2026-02-09	8-K	view ·
8-K	2026-02-09	8-K	view ·
8-K	2026-02-05	8-K	view ·
8-K	2026-02-05	8-K	view ·
4	2026-02-05	FORM 4	view ·
4	2026-02-05	FORM 4	view ·
4	2026-02-05	FORM 4	view ·
8-K	2026-01-30	8-K	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-29	FORM 4	view ·
4	2026-01-28	FORM 4	view ·
4	2026-01-23	FORM 4	view ·
4	2026-01-16	FORM 4	view ·
8-K	2026-01-06	8-K	view ·
4	2026-01-06	FORM 4	view ·
4	2025-12-29	FORM 4	view ·
DEF 14A	2025-12-18	DEF 14A	view ·
4	2025-12-17	FORM 4	view ·
4	2025-12-02	FORM 4	view ·
4	2025-12-02	FORM 4	view ·
4	2025-12-02	FORM 4	view ·
4	2025-12-01	FORM 4	view ·
4	2025-12-01	FORM 4	view ·
4	2025-12-01	FORM 4	view ·

About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collect…